Phosphodiesterase-5
Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction
... administered phosphodiesterase-5 inhibitor approved for the treatment of erectile ...other phosphodiesterase-5 inhibitors: vardenafi l and tadala- fi ...
8
Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
... Notes: Differentiated c2c12 muscle cells, 3T3-l1 adipocytes, or hepg2 cells were treated with indicated treatments for 24 hours. Ocr after 200 µM palmitate injection (A and C) was measured and the aUc was calculated. (A) ...
13
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
... Clinical and basic experimental evidence indicates that chronic inflammation is the greatest factor in benign prostatic hyperplasia (BPH) progression, which is the most common cause of Lower Urinary Tract Symptoms ...
8
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: Safety, tolerability, and efficacy
... Abstract: Pulmonary arterial hypertension (PAH) is a progressive disease that causes severe disability and has no cure. Over the past 20 years, a variety of treatment options have evolved for the management of PAH. With ...
11
A phosphodiesterase 5 inhibitor, tadalafil, suppresses stromal predominance and inflammation in a rat model of nonbacterial prostatitis
... values of 68.5 and 460 ng/ml in rats after single oral doses of tadalafil of 2 and 10 mg/kg, respectively are physiologically relevant with the clinical plasma concen- tration of tadalafil is 95.6 ng/ml when the drug is ...
7
RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity
... Figure 8. Protective effect of RhoBTB1 on Ang-II–induced hypertension. (A and B) Relative mRNA expression of RhoBTB1 was determined by qPCR in aorta from control (A) or S-RhoBTB1 (B) mice after injection of vehicle (corn ...
16
Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
... To indirectly quantify the contribution of prostanoids and other pathways not involving NO or prostanoids to the relaxation response induced by ACh, we designed an experiment in which two inhibitors, L-NAME and indo- ...
14
Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver
... systemic hemodynamics. With regard to cardiac output we calculated the values for fractional hepatic blood flow after drug injection (Figure 3, panel 3). These results revealed an increase in selective liver blood supply ...
10
Ocimum gratissimum Linn Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats
... The mechanisms or actions of cGMP are mainly de- creased by the phosphodiesterase-5 enzyme in diverse parts of corpus cavernosum [5]. PDE-5, an important enzyme of the NO/cGMP signaling ...
10
Taking the stress out of treating erectile dysfunction
... tion can be treated in most patients with stable coronary artery disease as long as precautions are taken to avoid interaction between phosphodiesterase 5 (PDE5) inhibitors and nitrates. However, patients ...
5
Hydroalcoholic Extract of Levisticum officinale Increases cGMP Signaling Pathway by Down-Regulating PDE5 Expression and Induction of Apoptosis in MCF-7 and MDA-MB-468 Breast Cancer Cell Lines
... Background: This study aimed to investigate Levisticum officinale hydroalcoholic extract (LOHE) effect on both cGMP signaling pathway and phosphodiesterase 5 (PDE5) gene expression pattern and to examine ...
7
Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
... Enrolled patients were allowed to be treatment naïve, in the event that no approved therapies were an option, or could be receiving an endothelin receptor antagonist, phosphodiesterase-5 inhibitor, or both. ...
8
Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension
... their pivotal findings demonstrating that intravenous (IV) epoprostenol improved 6-minute walk distance (6MWD) and hemodynamics. Though the patient numbers were small and the study duration was short, this remains the ...
7
Cardiovascular Disease Risk Assessment and Treatment of Erectile Dysfunction in Men with Diabetes Mellitus
... Phosphodiesterase 5 inhibitors have been described as the mainstay of oral medical treatment of ED in diabetic patients and include Sildenafil, Vardenafil and Tadalafil ...predominant ...
7
Assessment of the Role of NO-cGMP Pathway in Orthodontic Tooth Movement Using PDE5 Inhibitors: An Animal Study
... of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt ...al. Phosphodiesterase-5 inhibitors may facilitate bone defect ...
6
Pranathi Reddy R*, Bhavani D, Aleem Sarwar , Deepika S
... All the three phosphodiesterase inhibitors (PDE5) are metabolized by cytochrome P450 3A4 enzyme. Vardenafil undergoes substantial first pass metabolism. Hence, a lower starting dose of vardenafil is recommended in ...
7
Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies
... cases; 5) the follow-up durations for the included cohort studies; 6) the strategies used to confirm a diagnosis for melanoma; and 7) the adjusted variables for reporting the association between PDE5i use and ...
10
Murine AKAP7 Has a 2′,5′ Phosphodiesterase Domain That Can Complement an Inactive Murine Coronavirus ns2 Gene
... Cytoplasmic expression of the AKAP7 PDE rescues ns2 mu- tant MHV. AKAP7 is one of a relatively few members of the AKAP family that localizes to the nucleus (24, 39). Although expressed full-length AKAP7 traffics to ...
11
In Silico Mapping of Essential Residues in the Catalytic Domain of PDE5 Responsible for Stabilization of Its Commercial Inhibitors
... Abstract: Phosphodiesterase type 5 (PDE5) is an important enzyme associated with the hydrolysis of cyclic guanosine monophosphate (cGMP) to guanosine monophosphate ...
14
Cyclic nucleotide metabolism during the development of murine thymic lymphoma
... 'total' phosphodiesterase activity is not the most suitable approach for studying these enzymes in tumour ...AMP phosphodiesterase activity of normal ...
495